These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35525960)

  • 1. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease.
    Karagiannidis E; Moysidis DV; Papazoglou AS; Panteris E; Deda O; Stalikas N; Sofidis G; Kartas A; Bekiaridou A; Giannakoulas G; Gika H; Theodoridis G; Sianos G
    Cardiovasc Diabetol; 2022 May; 21(1):70. PubMed ID: 35525960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Relationship between Indexed Epicardial Adipose Tissue Thickness, Oxidative Stress in Adipocytes, and Coronary Artery Disease Complexity in Open-Heart Surgery Patients.
    Braescu L; Sturza A; Aburel OM; Sosdean R; Muntean D; Luca CT; Brie DM; Feier H; Crisan S; Mornos C
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276055
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of the stress hyperglycemia ratio with coronary artery disease complexity as assessed by the SYNTAX score in patients with acute coronary syndrome.
    Zhao S; Wang Z; Qing P; Li M; Liu Q; Wang K; Gao X; Zhao J; Wu Y
    Diabetol Metab Syndr; 2024 Jun; 16(1):139. PubMed ID: 38918810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study).
    Ahmed B; Bairey Merz CN; Johnson BD; Bittner V; Berga SL; Braunstein GD; Hodgson TK; Smith K; Shaw L; Kelsey SF; Sopko G;
    Am J Cardiol; 2008 Jul; 102(2):150-4. PubMed ID: 18602512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40-65: a prospective cross-sectional study.
    Zhang CY; Xu RQ; Wang XQ; Sun LF; Mo P; Cai RJ; Lin XZ; Luo CF; Ou WC; Lu LJ; Zhong Y; Chen JY
    Cardiovasc Diabetol; 2023 Aug; 22(1):219. PubMed ID: 37620823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease.
    Talmor-Barkan Y; Bar N; Shaul AA; Shahaf N; Godneva A; Bussi Y; Lotan-Pompan M; Weinberger A; Shechter A; Chezar-Azerrad C; Arow Z; Hammer Y; Chechi K; Forslund SK; Fromentin S; Dumas ME; Ehrlich SD; Pedersen O; Kornowski R; Segal E
    Nat Med; 2022 Feb; 28(2):295-302. PubMed ID: 35177859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Correlation of Serum Uric Acid Levels With the Severity of Coronary Artery Disease in Diabetic Patients: A Cross-Sectional Study.
    Khan SW; Fayyaz A; Ullah I; Shahab M; Naeem K; Ahmad B; Shah SM
    Cureus; 2023 Dec; 15(12):e50755. PubMed ID: 38239543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus.
    Düsing P; Heinrich NN; Al-Kassou B; Gutbrod K; Dörmann P; Nickenig G; Jansen F; Zietzer A
    BMC Cardiovasc Disord; 2023 Sep; 23(1):454. PubMed ID: 37700226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Coronary Artery Disease in Asymptomatic Pilots with Diabetes Mellitus.
    Zerrik M; Moumen A; El Ghazi M; Smiress FB; Iloughmane Z; El M'hadi C; Chemsi M
    Aerosp Med Hum Perform; 2024 Apr; 95(4):200-205. PubMed ID: 38486325
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolomics Profiling of Stages of Coronary Artery Disease Progression.
    Anlar GG; Anwardeen N; Al Ashmar S; Pedersen S; Elrayess MA; Zeidan A
    Metabolites; 2024 May; 14(6):. PubMed ID: 38921428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarkers Involved in Pulmonary Tuberculosis and Pulmonary Tuberculosis-Complicated Diabetes.
    Wang Y; He X; Zheng D; He Q; Sun L; Jin J
    Microbiol Spectr; 2023 Aug; 11(4):e0057723. PubMed ID: 37522815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-negligible association between SYNTAX score and anxiety-depressive disorders.
    Cerit L; Cerit Z; Duygu H
    Cardiovasc J Afr; 2023 Jan-Apr 23; 34(1):30-34. PubMed ID: 35980461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.
    Liu Y; Liu JE; He H; Qin M; Lei H; Meng J; Liu C; Chen X; Luo W; Zhong S
    Cardiovasc Diabetol; 2024 Jan; 23(1):14. PubMed ID: 38184583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic clinic-based investigation of echocardiogram parameters in asymptomatic patients with type 2 diabetes in routine clinical practice and its association with suggestive coronary artery disease: a pilot study.
    Palma CCSSV; Lopes PM; de Souza Bomfim A; Gomes MB
    Diabetol Metab Syndr; 2023 Jul; 15(1):162. PubMed ID: 37481586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and Coronary Artery Disease as Risk Factors for Dementia.
    Olesen KKW; Thrane PG; Gyldenkerne C; Thomsen RW; Mortensen JK; Kristensen SD; Maeng M
    Eur J Prev Cardiol; 2024 Apr; ():. PubMed ID: 38680097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between Type D Personality and the Complexity of Coronary Artery Disease.
    Enatescu VR; Cozma D; Tint D; Enatescu I; Simu M; Giurgi-Oncu C; Lazar MA; Mornos C
    Neuropsychiatr Dis Treat; 2021; 17():809-820. PubMed ID: 33776437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomic-Based Algorithms Can Enhance Prediction of Obstructive Coronary Artery Disease.
    Mouskeftara T; Deda O; Liapikos T; Panteris E; Karagiannidis E; Papazoglou AS; Gika H
    J Proteome Res; 2024 Aug; 23(8):3598-3611. PubMed ID: 39008891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus.
    Oe M; Fujihara K; Yamada MH; Osawa T; Kitazawa M; Matsubayashi Y; Sato T; Yaguchi Y; Iwanaga M; Yamada T; Sone H
    J Diabetes Investig; 2024 Aug; ():. PubMed ID: 39087859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients.
    Xu X; Xie Y; Gu X; Zhou Y; Kang Y; Liu J; Lai W; Lu H; Chen S; Xu JY; Lin F; Liu Y
    J Inflamm Res; 2023; 16():4031-4042. PubMed ID: 37719940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new risk score model to predict the presence of significant coronary artery disease in renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Bortolotto LA; de Lima JJ
    Transplant Res; 2013 Nov; 2(1):18. PubMed ID: 24176034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.